Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors. [electronic resource]
Producer: 20180917Description: 218-221 p. digitalISSN:- 1029-2403
- Animals
- Antineoplastic Agents -- pharmacology
- Boron Compounds -- pharmacology
- Bortezomib -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Profiling -- methods
- Glycine -- analogs & derivatives
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Hydroxamic Acids -- pharmacology
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Mice, SCID
- Prognosis
- Proteasome Inhibitors -- pharmacology
- U937 Cells
- Vorinostat
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.